Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG) Jame AbrahamHumberto CalderaChuck Vogel Review Open access 19 January 2018 Pages: 1 - 7
Is invasion a necessary step for metastases in breast cancer? Steven A. NarodVictoria Sopik Review Open access 20 January 2018 Pages: 9 - 23
GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer Yun-Bi NiJulia Y. S. TsangGary M. Tse Preclinical study 16 January 2018 Pages: 25 - 32
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement Timco KoopmanHenk J. BuikemaBert van der Vegt Preclinical study Open access 18 January 2018 Pages: 33 - 42
Impact of an embedded genetic counselor on breast cancer treatment Holly J. PedersonNajaah HussainStephen R. Grobmyer Preclinical study 18 January 2018 Pages: 43 - 46
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ Virginie OryWilliam B. KietzmanAnna T. Riegel Preclinical study 19 January 2018 Pages: 47 - 57
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients Zhenhua FanTao OuyangYuntao Xie Preclinical study 22 January 2018 Pages: 59 - 67
Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer Jie ChengTim Holland-LetzBarbara Burwinkel Clinical trial 16 January 2018 Pages: 69 - 82
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis Elisa García GarreGinés Luengo GilFrancisco Ayala de la Peña Clinical trial 16 January 2018 Pages: 83 - 92
Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial Sara MijwelMalin BackmanHelene Rundqvist Clinical trial Open access 18 January 2018 Pages: 93 - 103
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer Florentia FostiraEmmanouil SaloustrosIrene Konstantopoulou Epidemiology 15 January 2018 Pages: 105 - 113
Associations of coffee consumption and caffeine intake with mammographic breast density Lusine YaghjyanGraham ColditzRulla M. Tamimi Epidemiology 17 January 2018 Pages: 115 - 123
Assessment of potential risk factors for breast cancer in a population in Southern Brazil Juliana Zeni BreyerEliana Marcia WendlandLuciano Serpa Hammes Epidemiology 17 January 2018 Pages: 125 - 131
Living with chronic pain: perceptions of breast cancer survivors Ting BaoAndrew SeidmanJun J. Mao Epidemiology 19 January 2018 Pages: 133 - 140
Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry Tarsha JonesDebra DuquetteMaria C. Katapodi Epidemiology 20 January 2018 Pages: 141 - 152
Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence Charlotte PourcelotEmeline OrillardVirginie Nerich Epidemiology 23 January 2018 Pages: 153 - 162
Trajectories of quality of life following breast cancer diagnosis Neha G. GoyalBeverly J. LevineNancy E. Avis Epidemiology 24 January 2018 Pages: 163 - 173
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative Lu ZhangQingzhao YuTekeda Ferguson Epidemiology 24 January 2018 Pages: 175 - 187
Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience Krishan R. JethwaMohamed M. KahilaRobert W. Mutter Brief Report 18 January 2018 Pages: 189 - 196
Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience Nafisha LalaniKaren M. WinkfieldRachel B. Jimenez Brief Report 22 January 2018 Pages: 197 - 202
Detailed information about chemotherapy in breast control arm might affect cognitive sequelae compared with endocrine therapy patients Kadri Altundag Letter to the Editor 20 January 2018 Pages: 203 - 203